Press Releases :: Soliton, Inc. (SOLY)

Soliton Receives FDA Acceptance for 510(k) Application

Jul 15, 2020

Soliton to Present at COVID-19 Webinar Hosted by Maxim Group on July 16th, 2020

Jul 9, 2020

Soliton Files 510(k) with FDA for RAP Device for the Reduction of Cellulite

Jul 1, 2020

Soliton Announces Pricing of Public Offering

Jun 26, 2020

Soliton Announces Proposed Public Offering of Common Stock

Jun 25, 2020

Soliton Reports Positive Pivotal Cellulite Clinical Trial Results

Jun 15, 2020

Soliton To Announce Results of Pivotal Cellulite Clinical Trial

Jun 9, 2020

Soliton Announces Pivotal Cellulite Clinical Trial Results to be Presented at AAD Virtual Meeting June 12-14

May 18, 2020

Soliton Reports First Quarter 2020 Results

May 14, 2020

Soliton Announces First Quarter 2020 Financial Results and Business Update on Thursday, May 14, 2020

May 7, 2020

First Name*
First
Email*
Cell (Optional: Used For Press Releases)

© 2021 Soliton Inc. All Rights Reserved, Soliton Inc.